Issue 12/2015
Content (13 Articles)
Diverse effects of Brilliant Blue G administration in models of trigeminal activation in the rat
Zsuzsanna Bohár, Gábor Nagy-Grócz, Annamária Fejes-Szabó, Lilla Tar, Anna M. László, Alexandra Büki, Nikolett Szabadi, Veronika Vraukó, László Vécsei, Árpád Párdutz
Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson’s disease
Chi Wang Ip, Sandra K. Beck, Jens Volkmann
G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system
Qian Xiao, Suosuo Yang, Weidong Le
Small intestine dysfunction in Parkinson’s disease
Justyna Dutkiewicz, Stanisław Szlufik, Michał Nieciecki, Ingeborga Charzyńska, Leszek Królicki, Piotr Smektała, Andrzej Friedman
Characteristic laryngoscopic findings in Parkinson’s disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder
Takashi Tsuboi, Hirohisa Watanabe, Yasuhiro Tanaka, Reiko Ohdake, Noritaka Yoneyama, Kazuhiro Hara, Mizuki Ito, Masaaki Hirayama, Masahiko Yamamoto, Yasushi Fujimoto, Yasukazu Kajita, Toshihiko Wakabayashi, Gen Sobue
Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS)
Alexander Storch, Christine B. Schneider, Lisa Klingelhöfer, Per Odin, Gerd Fuchs, Wolfgang H. Jost, Pablo Martinez-Martin, Rainer Koch, Heinz Reichmann, K. Ray Chaudhuri, Georg Ebersbach
Vitamin D deficiency and its relationship with endothelial dysfunction in patients with early Parkinson’s disease
Jung Han Yoon, Dong Kyu Park, Seok Woo Yong, Ji Man Hong
Generalized motor inhibitory deficit in Parkinson’s disease patients who freeze
Patrick G. Bissett, Gordon D. Logan, Nelleke C. van Wouwe, Christopher M. Tolleson, Fenna T. Phibbs, Daniel O. Claassen, Scott A. Wylie
Is cognitive stability in Parkinson’s disease a predictable phenomenon? A 5-year follow-up study
Maria Elena Di Battista, Alfonso Rubino, Marcella Valente, Patrizia Giustini, Nicola Vanacore, Giuseppe Meco
Erratum to: Is cognitive stability in Parkinson’s disease a predictable phenomenon? A 5-year follow-up study
Maria Elena Di Battista, Alfonso Rubino, Marcella Valente, Patrizia Giustini, Nicola Vanacore, Giuseppe Meco
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off
Mikko Kuoppamäki, Mika Leinonen, Werner Poewe
Three novel presenilin 1 mutations marking the wide spectrum of age at onset and clinical patterns in familial Alzheimer’s disease
Sigrun Roeber, Felix Müller-Sarnowski, Julia Kress, Dieter Edbauer, Tanja Kuhlmann, Frank Tüttelmann, Christoph Schindler, Pia Winter, Thomas Arzberger, Ulrich Müller, Adrian Danek, Hans A. Kretzschmar
Fatty acid and vitamin interventions in adults with schizophrenia: a systematic review of the current evidence
Siok Ching Chia, Jeyakumar Henry, Yee Ming Mok, William G. Honer, Kang Sim